Ron Baron acquired 72.2 Thousand Genmab shares worth $2.08 Million. That's 0.01% of their equity portfolio (279th largest holding). The first Genmab trade was made in Q4 2020. Since then Ron Baron bought shares three more times and sold shares on ten occasions. The investor's estimated purchase price is $2.73 Million, resulting in a loss of 24%.